• 1
    Overall CM, Tam EM, Kappelhoff R, Connor A, Ewart T, Morrison CJ, et al. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol Chem 2004; 385: 493504.
  • 2
    Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463516.
  • 3
    Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M, et al. Matrix metalloproteinases in arthritic disease. Arthritis Res 2002; 4 Suppl 3: S3949.
  • 4
    Porter S, Clark IM, Kevorkian L, Edwards DR. The ADAMTS metalloproteinases. Biochem J 2005; 386: 1527.
  • 5
    Page Thomas DP, King B, Stephens T, Dingle JT. In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1. Ann Rheum Dis 1991; 50: 7580.
  • 6
    Jubb RW, Fell HB. The breakdown of collagen by chondrocytes. J Pathol 1980; 130: 15967.
  • 7
    Bryson H, Bunning RA, Feltell R, Kain CM, Kerrigan J, Power JC, et al. A serine proteinase inactivator inhibits chondrocyte-mediated cartilage proteoglycan breakdown occurring in response to pro-inflammatory cytokines. Arch Biochem Biophys 1998; 355: 1525.
  • 8
    Milner JM, Elliott SF, Cawston TE. Activation of procollagenases is a key control point in cartilage collagen degradation: interaction of serine and metalloproteinase pathways. Arthritis Rheum 2001; 44: 208496.
  • 9
    Milner JM, Rowan AD, Elliott SF, Cawston TE. Inhibition of furin-like enzymes blocks interleukin-1α/oncostatin M–stimulated cartilage degradation. Arthritis Rheum 2003; 48: 105766.
  • 10
    Murphy G, Cockett MI, Stephens PE, Smith BJ, Docherty AJ. Stromelysin is an activator of procollagenases: a study with natural and recombinant enzymes. Biochem J 1987; 248: 2658.
  • 11
    Knauper V, Wilhelm SM, Seperack PK, DeClerck YA, Langley KE, Osthues A, et al. Direct activation of human neutrophil procollagenases by recombinant stromelysin. Biochem J 1993; 295: 5816.
  • 12
    Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271: 154450.
  • 13
    Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H. Mechanisms of activation of tissue procollagenases by matrix metalloproteinase 3 (stromelysin). Biochemistry 1990; 29: 1026170.
  • 14
    Imai K, Yokohama Y, Nakanishi I, Ohuchi E, Fujii Y, Nakai N, et al. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells: activation of the precursor, interaction with other matrix metalloproteinase and enzymic properties. J Biol Chem 1995; 270: 66917.
  • 15
    Tchetverikov I, Lohmander LS, Verzijl N, Huizinga TW, TeKoppele JM, Hanemaaijer R. MMP protein and activity levels in synovial fluids from patients with joint injury, inflammatory arthritis and osteoarthritis. Ann Rheum Dis 2005; 64: 6948.
  • 16
    Lin PM, Chen CT, Torzilli PA. Increased stromelysin-1 (MMP-3) proteoglycan degradation (3B3– and 7D4) and collagen damage in cyclically load-injured articular cartilage. Osteoarthritis Cartilage 2004; 12: 48596.
  • 17
    Peake NJ, Khawaja K, Myers A, Jones D, Cawston TE, Rowan AD, et al. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study. Rheumatol 2005; 44: 13839.
  • 18
    Nakamura H, Fujii Y, Ohuchi E, Yamamoto E, Okada Y. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur J Biochem 1998; 253: 6775.
  • 19
    Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG, et al. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3 and MMP-10. Ann Rheum Dis 2002; 61: 97580.
  • 20
    Cawston TE, Curry VA, Summers CA, Clark IM, Riley GP, Life PF, et al. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint. Arthritis Rheum 1998; 41: 176071.
  • 21
    Rowan AD, Hui W, Cawston TE, Richards CD. Adenoviral gene transfer of interleukin-1 in combination with oncostatin M induces significant joint damage in a murine model. Am J Pathol 2003; 162: 197584.
  • 22
    Hui W, Cawston TE, Rowan AD. Transforming growth factor β1 and insulin-like growth factor-1 block collagen degradation induced by oncostatin M in combination with tumour necrosis factor α from bovine cartilage. Ann Rheum Dis 2003; 62: 1724.
  • 23
    Hui W, Rowan AD, Richards CD, Cawston TE. Oncostatin M in combination with tumour necrosis factor α induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum 2003; 48: 340418.
  • 24
    Hui W, Cawston TE, Richards CD, Rowan AD. A model of inflammatory arthritis highlights a role for oncostatin M in pro-inflammatory cytokine-induced bone destruction via RANK/RANKL. Arthritis Res Ther 2005; 7: R5764.
  • 25
    Barksby HE, Hui W, Wappler I, Peters HH, Milner JM, Richards CD, et al. Interleukin-1 in combination with oncostatin M up-regulates multiple genes in chondrocytes: implications for cartilage destruction and repair. Arthritis Rheum 2006; 54: 54050.
  • 26
    Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998; 25: 19914.
  • 27
    Shingleton WD, Ellis AJ, Rowan AD, Cawston TE. Retinoic acid combines with interleukin-1 to promote the degradation of collagen from bovine nasal cartilage: matrix metalloproteinases-1 and -13 are involved in cartilage collagen breakdown. J Cell Biochem 2000; 79: 51931.
  • 28
    Shah RL, Chen AC, Grodzinsky AJ, Trippel SB. Differential effects of bFGF and IGF-1 on matrix metabolism in calf and adult bovine cartilage experiments. Arch Biochem Biophys 1994; 308: 13747.
  • 29
    Tyler JA. Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines. Biochem J 1989; 260: 5438.
  • 30
    Luyten FP, Hascall VC, Nissley SP, Morales TI, Reddi AH. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants. Arch Biochem Biophys 1988; 267: 41625.
  • 31
    Hascall VC, Handley CJ, McQuillan DJ, Hascall GK, Robinson HC, Lowther DA. The effect of serum on biosynthesis of proteoglycans by bovine articular cartilage in culture. Arch Biochem Biophys 1983; 224: 20623.
  • 32
    Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL. Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 1995; 54: 2532.
  • 33
    O'Hare MC, Curry VA, Mitchell RE, Cawston TE. Stabilisation of purified human collagenase by site-directed mutagenesis. Biochem Biophys Res Commun 1995; 216: 32937.
  • 34
    Koshy PJ, Rowan AD, Life PF, Cawston TE. 96-well plate assays for measuring collagenase activity using 3H-acetylated collagen. Anal Biochem 1999; 275: 2027.
  • 35
    Fosang AJ, Neame PJ, Hardingham TE, Murphy G, Hamilton JA. Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins. J Biol Chem 1991; 266: 1557982.
  • 36
    Bergmann I, Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Anal Biochem 1963; 35: 19615.
  • 37
    Ellis AJ, Curry VA, Powell EK, Cawston TE. The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor. Biochem Biophys Res Commun 1994; 201: 94101.
  • 38
    Windsor LJ, Grenett H, Birkedal-Hansen B, Bodden MK, Engler JA, Birkedal-Hansen H. Cell type-specific regulation of SL-1 and SL-2 genes: induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J Biol Chem 1993; 268: 173417.
  • 39
    Konttinen YT, Ma J, Ruuttilal P, Hukkanen M, Santavirta S. Chondrocyte-mediated collagenolysis correlates with cartilage destruction grades in osteoarthritis. Clin Exp Rheumatol 2005; 23: 1926.
  • 40
    Dodge GR, Poole AR. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest 1989; 83: 64761.
  • 41
    Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004; ( 427 Suppl): S2736.
  • 42
    Goldring MB, Berenbaum F. The regulation of chondrocyte function by proinflammatory mediators: prostaglandins and nitric oxide. Clin Orthop Relat Res 2004;( 427 Suppl): S3746.
  • 43
    Kevorkian L, Young DA, Darrah C, Donell ST, Shepstone L, Porter S, et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum 2004; 1: 13141.
  • 44
    Pap T, van der Laan WH, Aupperle KR, Gay RE, Verheijen JH, Firestein GS, et al. Modulation of fibroblast-mediated cartilage degradation by articular chondrocytes in rheumatoid arthritis. Arthritis Rheum 2000; 43: 25316.
  • 45
    Haeusler G, Walter I, Helmreich M, Egerbacher M. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation. Calcif Tissue Int 2005; 76: 32635.
  • 46
    Bord S, Horner A, Hembry RM, Compston JE. Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: potential roles in skeletal development. Bone 1998; 23: 712.
  • 47
    He CS, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci U S A 1989; 86: 26326.
  • 48
    Lauhio A, Salo T, Ding Y, Konttinen YT, Nordstrom D, Tschesche H, et al. In vivo inhibition of human neutrophil collagenase (MMP-8) activity during long-term combination therapy of doxycycline and non-steroidal anti-inflammatory drugs (NSAID) in acute reactive arthritis. Clin Exp Immunol 1994; 98: 218.
  • 49
    Clark IM, Parker AE. Metalloproteinases: their role in arthritis and potential as therapeutic targets. Expert Opin Ther Targets 2003; 7: 1934.